Norway expects a shipment ofCOVID-19 vaccine from U.S. drugmaker Moderna due nextweek to be delayed to the following week, the NorwegianInstitute of Public Health (FHI) said on Wednesday. "There was supposed to have come 43,000 doses (next week),and those have been delayed to (the following week) according toour information," FHI Department Director Line Vold told a newsconference. As of Tuesday, close to 180,000 individuals in Norway hadreceived their first dose of vaccine against the disease andclose to 50,000 had received their second shot.
Virginia Mayo/AP/Shutterstock
Vaccines from Johnson & Johnson and Novavax report positive trial results
A coronavirus vaccine developed by the US firm Novavax has been shown to be 89 per cent effective in preventing covid-19 in clinical trials. The trials included participants in the UK and South Africa, and found the vaccine to be 86 per cent effective against the UK variant of the virus, but only 60 per cent effective against the variant in South Africa. Novavax said it will immediately begin development on a vaccine specifically targeted to the South African variant.
Advertisement
Janssen, a subsidiary of US firm Johnson & Johnson, announced that its covid-19 vaccine showed 66 per cent efficacy in an international trial. These results are based on a single dose of the vaccine, which makes it easier to administer than the two-shot vaccines that have already been approved. The company has said it will sell its vaccine on a not-for-profit basis.
Corona Sverige: Oron: Mutationerna sprids fritt i samhället expressen.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from expressen.se Daily Mail and Mail on Sunday newspapers.
Coronavirus latest news: UK getting safer every day as almost 1 in 5 adults have had first vaccine, says Nadhim Zahawi
Read full article
Oops!
The UK is getting safer every day as almost one in five adults have now had their first dose of the coronavirus vaccine, Nadhim Zahawi has said.
The NHS is on track to meet its target of vaccinating the top four priority groups by mid-February through a close focus on the most vulnerable , the vaccines minister told MPs.
More than nine in 10 people over the age of 80 have now had their first dose of the vaccine, as have nine in 10 over-75s and over half of all over-70s.
Denmark and Norway join European nations recommending against AstraZeneca vaccine for older people
By
James Frater, Arnaud Siad and Vasco Cotovio, CNN
Published Feb 5, 2021 1:30:22 AM
enablePagination: false
endIndex:
(CNN) - Denmark and Norway have joined a slew of European nations saying they won t give the Oxford/AstraZeneca coronavirus vaccine to people over 65, their national health agencies confirmed on Thursday.
Both cited a lack of data available on the use of the vaccine in older groups. We have reviewed the documentation, and until we have seen more data on efficacy among the elderly, it is our recommendation that the vaccine from AstraZeneca should first and foremost be an offer for people under 65, Bolette Søborg from Denmark’s National Board of Health said in a statement.